Paul Chapman has a strong industry track record of building Diagnostic and Life Sciences companies. He formerly served as CEO at Quanterix, Chief Operating Officer at OvaScience and President at ArjoHuntleigh. He also served as Global Vice President of Biopharm Process Solutions at EMD / Millipore / Sigma and as Global Vice President of Hospital Point of Care at Roche Diagnostics Near Patient Testing, a worldwide point of care in vitro diagnostics business.
Chief Executive Officer
Chief Scientific Officer (designated)
Dr. Xin Song is a multidisciplinary researcher with a keen interest in advancing the science and applications of nano/microscale technologies. His prior research experience spans wide-ranging topics including molecular computing, point-of-care diagnostics, micro/nanofabrication, DNA data storage, and optics-free microscopy. He has been published in various journals, books, and conferences. His recent innovations have resulted in 4 patent applications (two converted to PCT so far) in the field of microfabrication and molecular diagnostics. He holds a Ph.D. in Electrical & Computer Engineering from Duke University, a M.Sc. of Biomedical Engineering from Duke University, and a B.Sc. in Computer Engineering from the University of Virginia. He is currently serving as a postdoctoral associate at Duke University.
Dr. Jackie Walejko is a biochemist with experience uncovering small molecule biomarkers of disease. Her research expertise includes using metabolomic flux methods to uncover metabolic mechanisms leading to diabetic heart failure in fetuses and adults. Her work has resulted in over 11 peer-reviewed publications in journals such as Nature Communications, International Journal of Cardiology, and American Journal of Physiology Endocrinology and Metabolism. She holds a PhD in Biomedical Sciences from the University of Florida and a B.Sc. in Pharmacology and Toxicology from the University of Wisconsin-Madison.
Lead | Device Integration
Dr. Josh Buser is a scientist, engineer, and toolmaker focusing on biomarker quantification solutions for the past 14 years. He specializes in early-stage medical device technology development and transfer to manufacturing. He has been published in journals including Science Translational Medicine, the Annals of Neurology, and Lab on a Chip, with 24+ publications resulting in over 1600 citations. His innovations have resulted in 8+ patent applications (1 issued so far). His technical skills include microfluidics, supply chain development, laminate manufacturing for point-of-care diagnostics, fluid dynamics in porous media, non-electric precision temperature control, electronic design and fabrication, along with microscopy and quantitative image analysis. Josh performed his PhD and postdoc work with Paul Yager at the University of Washington Department of Bioengineering, and holds a B.S. in Mechanical Engineering from the University of Wisconsin-Madison.
Josh Beckmann combines a diverse background in small scale manufacturing, public health research, and prototyping. He currently specializes in applying simple technologies to novel medical device applications. His technical skills include: CAD design/rendering, digital fabrication, and electronic prototyping and fabrication. He holds a Masters of Public Health and Masters of Social Work from Boston University and a Bachelor of Arts in Sociology from University of Minnesota.
Lead | Design Engineering
Lead | Design for Manufacturing
Dan Morgan has been a key engineering contributor designing and developing medical, commercial and aerospace products with numerous companies for 40+ years. He has extensive knowledge of product design and manufacturing, including regulatory and design controls requirements. He has machine shop resources for a full in house quick turn prototyping. His extensive accomplishments include bone anchoring systems for multiple applications, SI Joint Fusion Systems, suturing and suture welding devices and suture passing and cutting devices, portable low cost patient monitors, ultrasonic and CT based diagnostic equipment, a full flow blood processing system, single use OTC blood collection and sample preparation products, semiconductor equipment, and tactical weapon systems. He has a BSME from the University of Lowell in Lowell MA and an AS in electronics from NSCC in Beverly MA.
Harald Casebourne Stock
Dr. Harald Casebourne Stock is a serial CEO and biotech (co-)founder. He has previously served as CEO at Grünenthal, ArjoHuntleigh, and OvaScience; co-founded Domus Diagnostics, EptivA Therapeutics, CognifiSense and a l t a, was Chair of the Board at Blue Therapeutics and NED at Consilient Health and Rentschler Biopharma. He is the former Senior Vice President at Roche Near Patient Testing, a worldwide point of care in-vitro diagnostics business. He earned a Ph.D. in Inorganic Chemistry from Heidelberg University.
Co-Founder & Executive Chair, Board of Directors
Dr. John Reif is a distinguished Full Professor at Duke University. He holds a Ph.D. & M.Sc. from Harvard University and a B.Sc. from Tufts University; he is an awarded Fellow at the Association for the Advancement of Science (AAAS), IEEE, ACM. He has 40 years of extensive experience in interdisciplinary research spanning computer science, mathematics, chemistry, physics, and more. He has 20 years of laboratory research experience, including performing as Head of Reif Lab at Duke University, in DNA and RNA nanoscience, molecular computing, molecular assembly, etc. He is the President of Eagle Eye Research, Inc.
Board Member, Advisor
Joe Gentile is an operating executive, board member, investor and strategy advisor with over 30 years of experience in medical devices, diagnostics and life science tools. Mr. Gentile began his career at the HP Medical Products Group where he spent 10 years in engineering, marketing, and corporate development. Later in his career he spent 14 years at Becton Dickinson in both corporate strategy and global business unit general management roles. More recently, he was CEO and Board member at Cellero Biosciences (acquired by Charles River Labs) and Stemgent Inc. (acquired by the ReproCell Group of Japan). He holds a B.Sc. from MIT, MBA from Boston University Questrom School of Business and a M.Eng. from Boston University College of Engineering.
Brandon Johnson has 15+ years of experience in medical diagnostics with a focus on consumer-oriented design. As founder and original CEO of Boston Microfluidics (Now Weavr Health), he raised $20M+, built a strategic relationship with Labcorp to develop the first product to enable home collection with results concordant with the previous gold standard, and contributed to over a dozen patents. He is an active consultant for start ups, investors, private equity funds, and companies in the Diagnostics and Pharmaceutical industry with a focus on migrating service to the home.